Promoting recovery and preventing drug-related mortality: Competing risks?

Journal of Public Health

Volumn 33, Issue 3, 2011, Pages 332-334

  Hickman, Matt ^a,b   Vickerman, Peter ^a,c   Robertson, Roy ^d,e   MacLeod, John ^a,f   Strang, John ^g,h  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Muirhouse Medical Group   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f Hartwood Healthcare   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

FEMALE; HEPATITIS C; HUMAN; MALE; REVIEW; SUBSTANCE ABUSE;

CRACK COCAINE; FEMALE; HEPATITIS C; HUMANS; MALE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 80052297395     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdr055     Document Type: Review

References (27)

1. National Treatment Agency. Commissioning for Recovery. London: NTA, 2010.
2. Home Office. Drug Strategy 2010 Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life. London: HMG, 2010.
3. White W, Mojer-Torres J. Recovery-Oriented Methadone Maintenance. Chicago, Philadepelphia, Pittsburgh: Great Lakes Addiction Technology Transfer Center, Philadelphia Department of Behavioral Health and Mental Retardation Services, Northeast Addiction Technology Transfer Center, 2010.
4. O'Brien C. Addiction and dependence in DSM-V. Addiction 2011;106(5):866-867.
5. Best DW, Ghufran S, Day E, Ray R, Loaring J. Breaking the habit: A retrospective analysis of desistance factors among formerly problematic heroin users. Drug Alcohol Rev 2008;27(6):619-624.
6. UK Drug Policy Commission. By their fruits applying payment by results to drugs recovery. UKDPC, 2011. www.ukdpc.org.uk/ publications.shtml#Localism.
7. Sainsbury Centre. Implementing Recovery: A New Framework for Organisational Change. Position paper. London: Sainsbury Centre for Mental Health, 2009.
8. Strang J, Hall W, Hickman M et al. The impact of supervised methadone consumption on opiate overdose deaths in England and Scotland: Analysis using the OD4 Index. BMJ 2010;341:c4851.
9. Kimber J, Copeland L, Hickman M et al. Survival and cessation in injecting opiate users, a prospective observational study of outcomes and the effect of opiate substitute treatment. BMJ 2010;340:c3172. doi:10.1136/bmj. c3172.
10. Cornish R, Macleod J, Strang J et al. Risk of death during and after opiate substitution treatment in primary care: Prospective observational study in UK general practice research database. BMJ 2010;341:c5475.
11. Degenhardt L, Randall D, Hall W et al. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug Alcohol Depend 2009;105(1-2): 9-15.
12. Davoli M, Bargagli AM, Perucci CA et al. Risk of fatal overdose during and after specialist drug treatment: The VEdeTTE study, a national multi-site prospective cohort study. Addiction 2007;102(12):1954-1959. (Pubitemid 350145672)
13. Farrell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008;103(2): 251-255.
14. Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction 2003;98(2): 185-190. (Pubitemid 36140370)
15. Morgan O, Griffiths C, Hickman M. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int J Epidemiol 2006;35(6):1579-1585. (Pubitemid 46178937)
16. Morgan O, Griffiths C, Toson B et al. Trends in deaths related to drug misuse in England and Wales, 1993-2004. Health Stat Q 2006;(31):23-27.
17. Office for National Statistics. Deaths Related to Drug Poisoning in England and Wales, 2009. London: ONS. Statistical Bulletin, 2010.
18. Amato L, Davoli M, Perucci CA et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Substance Abuse Treatment 2005;28(4):321-329. (Pubitemid 40733141)
19. Bell JR, Young MR, Masterman SC et al. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust 1999;171(1):26-30. (Pubitemid 29342244)
20. Strang J, McCambridge J, Best D et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: Follow up study. BMJ 2003;326(7396):959-960. (Pubitemid 36543192)
21. Fugelstad A, Stenbacka M, Leifman A et al. Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings. Addiction 2007;102(3):406-412. (Pubitemid 46239366)
22. Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: Impact of methadone treatment. Acta Psychiatr Scand 1990;82(3):223-227. (Pubitemid 20329007)
23. The Scottish Government. National Forum on Drug Related Deaths in Scotland, Annual Report 2009-10. Edinburgh: The Scottish Government, 2010.
24. Hickman M, Hope V, Coleman B et al. Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: Implications for public health action. J Public Health (Oxf) 2009;31(3):374-382.
25. Gossop M, Stewart D, Treacy S et al. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002;97(1):39-47. (Pubitemid 34038191)
26. Hser Y, Hoffman V, Grella C et al. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001;58:503-508. (Pubitemid 32411332)
27. Strang J. Breaking out of procruste's bed services for problem drug takers. Psychiatric Bull 1985;9:150-152.